THIS CONTENT IS BROUGHT TO YOU BY the Norwegian centre for E-health research – read more
Annually, around 250,000 women in Norway are screened for breast cancer, which captures a standard set of four images per woman. This translates to a substantial dataset of 1 million images each year.
The use of
artificial intelligence will contribute to even better diagnostic imaging for
patients. The Norwegian Centre for E-health Research is conducting follow-up
research on the project.
The goal is to improve the healthcare service and free radiologist resources, enabling them to allocate more time to advanced examinations, where time can be more crucial for patients.
Using artificial intelligence (AI) for this purpose can improve healthcare for half the population of Norway within a short time.
“We aim for AI to enhance the daily work experience for our radiologists by assisting them in managing the substantial volume of diagnostics and offering valuable professional support. While AI may not address all the challenges, it will undoubtedly make a significant contribution,” Jon Haakon Malmer-Høvik says.
He is head of the Department of Diagnostic Imaging at Vestre Viken Hospital Trust.
Enhances quality and efficiency
With the
new AI solution, X-ray images captured at the hospital will be transmitted to a
cloud-based service.
Within this system, algorithms analyse the images, and the AI-generated
responses are then returned to an image storage system.
This process aims to enhance the quality and
efficiency of patient pathways and the radiologists’ workflow.
Researchers
need to get involved early
While the
healthcare sector should embrace AI utilisation, there is a pressing need for
research to explore both the opportunities and challenges presented by the
medical application of artificial intelligence.
Researchers from the Norwegian Centre for E-health
Research have been engaged in the project from its inception and are currently
conducting ongoing follow-up research. This involves closely monitoring the
implementation of artificial intelligence in the Department of Diagnostic
Imaging at Vestre Viken Hospital Trust over an extended period.
“We
are currently collaborating with the Norwegian Directorate of Health and Vestre
Viken on a follow-up research project that explores the prerequisites for the
effective implementation of artificial intelligence,” Line Silsand says.
She is a researcher in the Department for Patient Pathways at the Norwegian
Centre for E-health Research.
“We
are evaluating aspects of procurement, implementation, and the associated
benefits, and we will provide ongoing updates to the project team to facilitate
adjustments as needed,” she says.
Expectations
and challenges
Artificial
intelligence in radiology holds the promise of efficiently managing the growing
influx of imaging examinations.
However,
the adoption of AI introduces fresh challenges concerning ICT security, data
quality, privacy, ethics, and organisational dynamics.
“Artificial
intelligence holds the potential to facilitate early disease detection, thereby
enhancing patient survival rates. It also plays a crucial role in optimising
patient prioritisation, ensuring timely and appropriate healthcare delivery,” Silsand says.
However, she adds, to deploy AI technologies safely and effectively, it’s crucial to conduct research into the clinical application processes. This will help the researchers understand the prerequisites for the successful incorporation of AI.
Major
savings
Annually,
the Norwegian Breast Cancer Screening Programme screens around 250,000 women,
capturing a standard set of four images per woman. This translates to a
substantial dataset of 1 million images each year.
Currently,
two radiologists independently interpret these images.
If artificial intelligence could effectively select half of these, it would represent a substantial relief for radiologists.
“We’re currently facing a significant shortage of breast radiologists, and our
objective is to optimise their time through the integration of AI. In addition
to improving screening examination sensitivity, we aim to achieve long-term
cost-effectiveness,” Solveig Hofvind says.
She is head of the Breast Cancer Screening Programme at the Cancer Registry of Norway.
“To realise this goal, we are dedicated to developing and
testing both proprietary and CE-marked algorithms within the Screening
Programme to identify and implement the most effective solutions,” she says.